This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 3270 results found since Jan 2013.

A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy
Condition:   Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Intervention:   Drug: Rituximab Sponsor:   Istituto Clinico Humanitas Active, not recruiting
Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials

Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex ® 10%) in patients with chronic inflammatory demyelinating polyneuropathy
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by progressive weakness and sensory loss, often affecting patient ’s ability to walk and perform activities of daily living inde...
Source: BMC Neurology - May 26, 2023 Category: Neurology Authors: Juliane Klehmet, Bj örn Tackenberg, Judith Haas and Bernd C. Kieseier Tags: Research Source Type: research

Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study
ConclusionA heavy burden of symptoms, comorbidities, and diagnostic testing exists in patients with CIDP initiating IVIG. Characteristics of patients with CIDP initiating different IVIG products are well balanced, suggesting an absence of clinical or demographic determinants underlying IVIG selection.
Source: Neurology and Therapy - May 17, 2023 Category: Neurology Source Type: research

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
ConclusionThis real-world analysis of IVIG treatment patterns and treatment and safety outcomes of patients with CIDP who initiated IVIG highlights the unmet need for improved long-term management. Further research is needed to evaluate the use of functional status measures as endpoints for immunoglobulin treatment effectiveness.
Source: Neurology and Therapy - May 12, 2023 Category: Neurology Source Type: research

Pediatric-onset chronic inflammatory demyelinating polyneuropathy: a multicenter study
To evaluate the clinical, demographic features, and treatment modalities of pediatric-onset chronic inflammatory demyelinating polyneuropathy (CIDP) in Turkey.
Source: Pediatric Neurology - May 4, 2023 Category: Neurology Authors: Gamze Sar ıkaya Uzan, Atay Vural, Deniz Yüksel, Erhan Aksoy, Ülkühan Öztoprak, Mehmet Canpolat, Selcan Öztürk, Çelebi Yıldırım, Ayten Güleç, Hüseyin Per, Hakan Gümüş, Çetin Okuyaz, Meltem Çobanoğulları Direk, Mustafa Kömür, Aycan Ü Tags: Research Paper Source Type: research

Chronic inflammatory neuropathies and their impact on activities and participation
CONCLUSION AND KEY FINDINGS: Activity limitations and restrictions in participation are common in CIDP patients and to a lesser extent in MMN patients. Fatigue, pain and resilience independently contributed to perceived limitations in CIDP patients. Referral to rehabilitation physician is warranted, to address these limitations appropriately.PMID:37038272 | DOI:10.1111/ene.15815
Source: Pain Physician - April 11, 2023 Category: Anesthesiology Authors: H A Wonink W J Kruithof H S Goedee A Beelen Source Type: research